Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

Antiprothrombin antibodies: a comparative analysis of homemade and commercial methods. A collaborative study by the Forum Interdisciplinare per la Ricerca nelle Malattie Autoimmuni (FIRMA).

Tincani A, Morozzi G, Afeltra A, Alessandri C, Allegri F, Bistoni O, Bizzaro N, Caccavo D, Galeazzi M, Gerli R, Giovannelli L, Longobardo G, Lotzniker M, Malacarne F, Migliorini P, Parodi A, Pregnolato F, Radice A, Riccieri V, Ruffelli M, Sinico RA, Tozzoli R, Villalta D, Marcolongo R, Meroni P; Forum Interdisciplinare per la Ricerca nelle Malattie Autoimmuni (FIRMA)..

Clin Exp Rheumatol. 2007 Mar-Apr;25(2):268-74.

PMID:
17543152
2.

Prevalence of antibodies to prothrombin in solid phase (aPT) and to phosphatidylserine-prothrombin complex (aPS/PT) in patients with and without lupus anticoagulant.

Bertolaccini ML, Sciascia S, Murru V, Garcia-Fernandez C, Sanna G, Khamashta MA.

Thromb Haemost. 2013 Feb;109(2):207-13. doi: 10.1160/TH12-07-0527. Epub 2012 Dec 20.

PMID:
23254928
3.

Comparative analysis of different enzyme immunoassays for assessment of phosphatidylserine-dependent antiprothrombin antibodies.

Amengual O, Horita T, Binder W, Norman GL, Shums Z, Kato M, Otomo K, Fujieda Y, Oku K, Bohgaki T, Yasuda S, Atsumi T.

Rheumatol Int. 2014 Sep;34(9):1225-30. doi: 10.1007/s00296-014-2951-0. Epub 2014 Feb 5.

PMID:
24497039
4.
5.

Laboratory evaluation of anti-phospholipid syndrome: a preliminary prospective study of phosphatidylserine/prothrombin antibodies in an at-risk patient cohort.

Heikal NM, Jaskowski TD, Malmberg E, Lakos G, Branch DW, Tebo AE.

Clin Exp Immunol. 2015 May;180(2):218-26. doi: 10.1111/cei.12573.

6.

The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.

Bertolaccini ML, Atsumi T, Escudero Contreras A, Khamashta MA, Hughes GR.

J Rheumatol. 2001 Dec;28(12):2637-43.

PMID:
11764209
7.

Autoantibodies against phosphatidylserine, prothrombin and phosphatidylserine-prothrombin complex: identical or distinct diagnostic tools for antiphospholipid syndrome?

Jaskowski TD, Wilson AR, Hill HR, Branch WD, Tebo AE.

Clin Chim Acta. 2009 Dec;410(1-2):19-24. doi: 10.1016/j.cca.2009.09.006. Epub 2009 Sep 12.

PMID:
19751711
8.

Antiphospholipid antibody tests: spreading the net.

Bertolaccini ML, Gomez S, Pareja JF, Theodoridou A, Sanna G, Hughes GR, Khamashta MA.

Ann Rheum Dis. 2005 Nov;64(11):1639-43. Epub 2005 Apr 7.

10.

Antiphosphatidylserine/prothrombin antibodies in primary antiphospholipid syndrome.

Hoxha A, Ruffatti A, Tonello M, Bontadi A, Salvan E, Banzato A, Pengo V, Punzi L.

Lupus. 2012 Jun;21(7):787-9. doi: 10.1177/0961203312441983.

PMID:
22635234
11.

Diagnostic value of antibodies to phosphatidylserine/prothrombin complex for antiphospholipid syndrome in Chinese patients.

Zhu L, Li C, Liu N, Yang X, Jia RL, Mu R, Su Y, Li ZG.

Clin Rheumatol. 2017 Feb;36(2):401-406. doi: 10.1007/s10067-016-3498-0. Epub 2017 Jan 3.

PMID:
28050648
12.

APhL antibody ELISA as an alternative to anticardiolipin test for the diagnosis of antiphospholipid syndrome.

Suh-Lailam BB, Cromar A, Davis KW, Tebo AE.

Int J Clin Exp Pathol. 2012;5(3):210-5. Epub 2012 Mar 25.

13.

Relationship between antiphosphatidylserine/prothrombin and conventional antiphospholipid antibodies in primary antiphospholipid syndrome.

Hoxha A, Ruffatti A, Mattia E, Meneghel L, Tonello M, Salvan E, Pengo V, Punzi L.

Clin Chem Lab Med. 2015 Jul;53(8):1265-70. doi: 10.1515/cclm-2014-1129.

PMID:
25562605
14.

Antiprothrombin antibody: why do we need more assays?

Atsumi T, Koike T.

Lupus. 2010 Apr;19(4):436-9. doi: 10.1177/0961203310361487.

PMID:
20353984
16.

Clinical significance of antiphospholipid protein antibodies. Receiver operating characteristics plot analysis.

Musial J, Swadzba J, Motyl A, Iwaniec T.

J Rheumatol. 2003 Apr;30(4):723-30.

PMID:
12672190
17.

Antiprothrombin antibodies detected in two different assay systems. Prevalence and clinical significance in systemic lupus erythematosus.

Bertolaccini ML, Atsumi T, Koike T, Hughes GR, Khamashta MA.

Thromb Haemost. 2005 Feb;93(2):289-97.

PMID:
15711745
18.

High titer of anti-phosphatidylserine-prothrombin complex antibodies in patients with cutaneous polyarteritis nodosa.

Kawakami T, Yamazaki M, Mizoguchi M, Soma Y.

Arthritis Rheum. 2007 Dec 15;57(8):1507-13.

19.

Validation of a commercially available kit to detect anti-phosphatidylserine/prothrombin antibodies in a cohort of systemic lupus erythematosus patients.

Sciascia S, Sanna G, Murru V, Khamashta MA, Bertolaccini ML.

Thromb Res. 2014 Mar;133(3):451-4. doi: 10.1016/j.thromres.2013.12.001. Epub 2013 Dec 7.

PMID:
24342537
20.

Anti-prothrombin (aPT) and anti-phosphatidylserine/prothrombin (aPS/PT) antibodies and the risk of thrombosis in the antiphospholipid syndrome. A systematic review.

Sciascia S, Sanna G, Murru V, Roccatello D, Khamashta MA, Bertolaccini ML.

Thromb Haemost. 2014 Feb;111(2):354-64. doi: 10.1160/TH13-06-0509. Epub 2013 Oct 31. Review.

PMID:
24172938

Supplemental Content

Support Center